Pictet Asset Management
TMO icon

Pictet Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Pictet Asset Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$538M Sell
1,073,670
-987,673
-48% -$474M 0.51% 36
2026
Q1 		$1.01B Sell
2,061,343
-400,813
-16% -$218M 1.07% 9
2025
Q4 		$1.43B Sell
2,462,156
-428,284
-15% -$242M 1.38% 8
2025
Q3 		$1.4B Buy
2,890,440
+42,003
+1% +$19.6M 1.35% 8
2025
Q2 		$1.16B Sell
2,848,437
-30,837
-1% -$12.9M 1.18% 12
2025
Q1 		$1.43B Buy
2,879,274
+193,378
+7% +$105M 1.59% 5
2024
Q4 		$1.4B Buy
2,685,896
+196,242
+8% +$108M 1.51% 6
2024
Q3 		$1.54B Buy
2,489,654
+1,995
+0.1% +$1.18M 1.69% 5
2024
Q2 		$1.38B Sell
2,487,659
-72,667
-3% -$41.6M 1.58% 6
2024
Q1 		$1.49B Sell
2,560,326
-64,410
-2% -$36.1M 1.62% 3
2023
Q4 		$1.39B Buy
2,624,736
+104,448
+4% +$50.6M 1.54% 5
2023
Q3 		$1.28B Buy
+2,520,288
New +$1.34B 1.57% 4

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Pictet Asset Management's TMO Position: Q2 2026 in Review

Pictet Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 48% in Q2 2026, selling an estimated $474M and leaving 1,073,670 shares worth $538M. The position accounts for 0.51% of the portfolio, ranked #36.

Pictet Asset Management first reported a position in TMO in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.54B in Q3 2024. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Pictet Asset Management held 1,073,670 shares of Thermo Fisher Scientific worth $538M as of Q2 2026.
  • Pictet Asset Management sold 987,673 Thermo Fisher Scientific shares in Q2 2026, an estimated $474M.
  • Thermo Fisher Scientific made up 0.51% of Pictet Asset Management's portfolio in Q2 2026, its #36 holding.
  • Pictet Asset Management first reported a position in Thermo Fisher Scientific in Q3 2023 and has held it in 12 quarters since.
  • Pictet Asset Management's Thermo Fisher Scientific position peaked at $1.54B in Q3 2024.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.